PDGFRL and non-small cell lung carcinoma: For example, LOH is a frequent event for BRCA1 in breast and ovarian cancers, for MSH3 in breast, bladder and non-small cell lung cancers, and for PDGFRL in sporadic hepatocellular carcinomas, colorectal and non-small cell lung cancers.